{"id":"https://openalex.org/W4392521367","doi":"https://doi.org/10.1200/po.23.00527","title":"Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study","display_name":"Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study","publication_year":2024,"publication_date":"2024-03-06","ids":{"openalex":"https://openalex.org/W4392521367","doi":"https://doi.org/10.1200/po.23.00527","pmid":"https://pubmed.ncbi.nlm.nih.gov/38603652","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10896467"},"language":"en","primary_location":{"id":"doi:10.1200/po.23.00527","doi":"https://doi.org/10.1200/po.23.00527","is_oa":false,"landing_page_url":"https://doi.org/10.1200/po.23.00527","pdf_url":null,"source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10896467/pdf/po-8-e2300527.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076767039","display_name":"Vaibhav Sahai","orcid":"https://orcid.org/0000-0003-1892-1548","observed_orcids":["https://orcid.org/0000-0003-1892-1548"]},"institutions":[{"id":"https://openalex.org/I4390039285","display_name":"U-M Rogel Cancer Center","ror":"https://ror.org/05asdy483","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445","https://openalex.org/I4390039285"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaibhav Sahai","raw_affiliation_strings":["University of Michigan Rogel Cancer Center, Ann Arbor, MI"],"raw_orcid":"https://orcid.org/0000-0003-1892-1548","affiliations":[{"raw_affiliation_string":"University of Michigan Rogel Cancer Center, Ann Arbor, MI","institution_ids":["https://openalex.org/I4390039285"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Rothe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Rothe","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058562764","display_name":"Pam K. Mangat","orcid":"https://orcid.org/0000-0001-8571-6742","observed_orcids":["https://orcid.org/0000-0001-8571-6742"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pam K. Mangat","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":"https://orcid.org/0000-0001-8571-6742","affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029296725","display_name":"Elizabeth S. Garrett-Mayer","orcid":"https://orcid.org/0000-0003-4709-0333","observed_orcids":["https://orcid.org/0000-0003-4709-0333"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Garrett-Mayer","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":"https://orcid.org/0000-0003-4709-0333","affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022342621","display_name":"Vijay Suhag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114073160","display_name":"Sutter Health","ror":"https://ror.org/0060avh92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160"]},{"id":"https://openalex.org/I4210125323","display_name":"Sutter Roseville Medical Center","ror":"https://ror.org/025srm412","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I4210125323"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vijay Suhag","raw_affiliation_strings":["Sutter Health Roseville Cancer Center, Roseville, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutter Health Roseville Cancer Center, Roseville, CA","institution_ids":["https://openalex.org/I114073160","https://openalex.org/I4210125323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000978986","display_name":"Elie G. Dib","orcid":"https://orcid.org/0000-0002-7851-5165","observed_orcids":["https://orcid.org/0000-0002-7851-5165"]},"institutions":[{"id":"https://openalex.org/I4210119866","display_name":"Michigan Cancer Research Consortium","ror":"https://ror.org/02mfxyv79","country_code":"US","type":"other","lineage":["https://openalex.org/I4210119866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elie G. Dib","raw_affiliation_strings":["Michigan Cancer Research Consortium, Ypsilanti, MI"],"raw_orcid":"https://orcid.org/0000-0002-7851-5165","affiliations":[{"raw_affiliation_string":"Michigan Cancer Research Consortium, Ypsilanti, MI","institution_ids":["https://openalex.org/I4210119866"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004690917","display_name":"Inderjit Mehmi","orcid":"https://orcid.org/0000-0002-2253-2206","observed_orcids":["https://orcid.org/0000-0002-2253-2206"]},"institutions":[{"id":"https://openalex.org/I4210104507","display_name":"Angeles Clinic and Research Institute","ror":"https://ror.org/01ct2ab72","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834","https://openalex.org/I4210104507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Inderjit Mehmi","raw_affiliation_strings":["The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, CA","institution_ids":["https://openalex.org/I4210104507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074396684","display_name":"Kunal C. Kadakia","orcid":"https://orcid.org/0000-0003-3574-4141","observed_orcids":["https://orcid.org/0000-0003-3574-4141","https://orcid.org/0000-0002-7421-0591"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kunal C. Kadakia","raw_affiliation_strings":["Levine Cancer Institute, Atrium Health, Charlotte, NC"],"raw_orcid":"https://orcid.org/0000-0003-3574-4141","affiliations":[{"raw_affiliation_string":"Levine Cancer Institute, Atrium Health, Charlotte, NC","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076492419","display_name":"Evan P. Pisick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan Pisick","raw_affiliation_strings":["City of Hope Chicago, Zion, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Chicago, Zion, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047690131","display_name":"Herbert Leon Duvivier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert L. Duvivier","raw_affiliation_strings":["City of Hope Atlanta, Newnan, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Atlanta, Newnan, GA","institution_ids":["https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028897969","display_name":"Phat H. Le","orcid":"https://orcid.org/0000-0002-9447-8149","observed_orcids":["https://orcid.org/0000-0002-9447-8149"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phat Le","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":"https://orcid.org/0000-0002-9447-8149","affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rui Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Li","raw_affiliation_strings":["Providence Cancer Institute, Providence Portland Medical Center, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Cancer Institute, Providence Portland Medical Center, Portland, OR","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115589584","display_name":"David P. Michelin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316844076","display_name":"Munson Medical Center","ror":"https://ror.org/005qzv038","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316844076"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Michelin","raw_affiliation_strings":["Munson Medical Center, Cancer Research Consortium of West Michigan, Traverse City, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Munson Medical Center, Cancer Research Consortium of West Michigan, Traverse City, MI","institution_ids":["https://openalex.org/I1316844076"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090867973","display_name":"Ryan Eldredge Wilcox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108785884","display_name":"Intermountain Healthcare","ror":"https://ror.org/04mvr1r74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I108785884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan E. Wilcox","raw_affiliation_strings":["Intermountain Healthcare, St George, UT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intermountain Healthcare, St George, UT","institution_ids":["https://openalex.org/I108785884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078986413","display_name":"Gina N. Grantham","orcid":"https://orcid.org/0000-0002-3111-0419","observed_orcids":["https://orcid.org/0000-0002-3111-0419"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gina N. Grantham","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":"https://orcid.org/0000-0002-3111-0419","affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085149228","display_name":"Dominique C. Hinshaw","orcid":"https://orcid.org/0000-0002-2052-9484","observed_orcids":["https://orcid.org/0000-0002-2052-9484"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominique C. Hinshaw","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":"https://orcid.org/0000-0002-2052-9484","affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071424584","display_name":"Abigail Gregory","orcid":"https://orcid.org/0000-0001-9189-4369","observed_orcids":["https://orcid.org/0000-0001-9189-4369"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abigail Gregory","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":"https://orcid.org/0000-0001-9189-4369","affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053535513","display_name":"Susan Halabi","orcid":"https://orcid.org/0000-0003-4135-2777","observed_orcids":["https://orcid.org/0000-0003-4135-2777"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Halabi","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":"https://orcid.org/0000-0003-4135-2777","affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031299191","display_name":"Richard L. Schilsky","orcid":"https://orcid.org/0000-0003-4474-4303","observed_orcids":["https://orcid.org/0000-0003-4474-4303"]},"institutions":[{"id":"https://openalex.org/I1315885867","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1315885867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard L. Schilsky","raw_affiliation_strings":["American Society of Clinical Oncology, Alexandria, VA"],"raw_orcid":"https://orcid.org/0000-0003-4474-4303","affiliations":[{"raw_affiliation_string":"American Society of Clinical Oncology, Alexandria, VA","institution_ids":["https://openalex.org/I1315885867"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8509,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.73735173,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"8","issue":"8","first_page":"e2300527","last_page":"e2300527"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.47679999470710754,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.47679999470710754,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.3458999991416931,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.08590000122785568,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":1.0},{"id":"https://openalex.org/keywords/braf-alterations","display_name":"BRAF alterations","score":0.9950000047683716},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.925000011920929},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7059999704360962},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.5950000286102295},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.7450000047683716},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9079999923706055},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8629999756813049},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8019999861717224},{"id":"https://openalex.org/keywords/basket-trials","display_name":"basket trials","score":0.492000013589859},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.8352607488632202},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8018567562103271},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7057422399520874},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6152418255805969},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6098048686981201},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5639835596084595},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.5439983606338501},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5409955978393555},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.46868282556533813},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4383087456226349},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38921117782592773},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3593711853027344},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.33340510725975037},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30968308448791504},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.23320460319519043}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/po.23.00527","doi":"https://doi.org/10.1200/po.23.00527","is_oa":false,"landing_page_url":"https://doi.org/10.1200/po.23.00527","pdf_url":null,"source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10896467","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10896467","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10896467/pdf/po-8-e2300527.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precis Oncol","raw_type":"Text"},{"id":"pmid:38603652","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38603652","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO precision oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10896467","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10896467","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10896467/pdf/po-8-e2300527.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precis Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4392521367.pdf","grobid_xml":"https://content.openalex.org/works/W4392521367.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W2048025430","https://openalex.org/W2056657908","https://openalex.org/W2105637242","https://openalex.org/W2168711434","https://openalex.org/W2768933447","https://openalex.org/W2789665281","https://openalex.org/W2832093183","https://openalex.org/W2887362262","https://openalex.org/W2941090871","https://openalex.org/W2952795149","https://openalex.org/W2968474136","https://openalex.org/W2972281129","https://openalex.org/W3037255929","https://openalex.org/W3037624356","https://openalex.org/W3040145735","https://openalex.org/W3089535779","https://openalex.org/W3093065681","https://openalex.org/W3094617408","https://openalex.org/W3152698713","https://openalex.org/W3209579382","https://openalex.org/W4213091130","https://openalex.org/W4234015415","https://openalex.org/W4255291191","https://openalex.org/W4306168108","https://openalex.org/W4307883113","https://openalex.org/W4309669102","https://openalex.org/W4319457822","https://openalex.org/W4362703744","https://openalex.org/W4365510427","https://openalex.org/W4375947164","https://openalex.org/W4385726646"],"related_works":["https://openalex.org/W4389745624","https://openalex.org/W4309669102","https://openalex.org/W4286298884","https://openalex.org/W3094617408","https://openalex.org/W4389250341","https://openalex.org/W7159688848","https://openalex.org/W4385726646","https://openalex.org/W7104180560","https://openalex.org/W4399737606","https://openalex.org/W7222633483"],"abstract_inverted_index":{"PURPOSE":[0],"Targeted":[1],"Agent":[2],"and":[3,70,168,198,206,216],"Profiling":[4],"Utilization":[5],"Registry":[6],"is":[7],"a":[8,37,117,132,138,267],"phase":[9],"II":[10],"basket":[11],"trial":[12],"evaluating":[13],"the":[14,129],"antitumor":[15],"activity":[16,270],"of":[17,36,39,87,98,131,142,162,165,209,227,269],"commercially":[18],"available":[19],"targeted":[20],"agents":[21],"in":[22,271],"patients":[23,40,54,88,172,189,195,239,272],"with":[24,27,41,44,48,89,108,112,137,173,177,196,200,273,276],"advanced":[25],"cancer":[26],"genomic":[28],"alterations":[29,46,110,179],"known":[30],"to":[31,185,214,221,256,265],"be":[32],"drug":[33],"targets.":[34],"Results":[35],"cohort":[38,120],"solid":[42,274],"tumors":[43,275],"BRAF":[45,109,178,277],"treated":[47,111],"regorafenib":[49,113],"are":[50],"reported.":[51],"METHODS":[52],"Eligible":[53],"had":[55,240],"measurable":[56],"disease":[57,80,97],"(RECIST":[58],"v.1.1),":[59],"Eastern":[60],"Cooperative":[61],"Oncology":[62],"Group":[63],"performance":[64],"status":[65],"0-1,":[66],"adequate":[67],"organ":[68],"function,":[69],"no":[71],"standard":[72],"treatment":[73],"options.":[74],"The":[75,124,224],"primary":[76],"end":[77,151],"point":[78],"was":[79,231],"control":[81],"(DC),":[82],"defined":[83],"as":[84],"investigator":[85],"assessment":[86],"complete":[90],"or":[91,95,248],"partial":[92],"response":[93,155],"(PR)":[94],"stable":[96,166],"at":[99,241,252],"least":[100,242,253],"16-weeks":[101],"duration":[102,161,164],"(SD16+).":[103],"Low":[104],"accruing":[105],"histology-specific":[106],"cohorts":[107],"were":[114,126,153,180,190,202],"collapsed":[115],"into":[116],"single":[118],"histology-pooled":[119],"for":[121,192,204],"this":[122],"analysis.":[123],"results":[125],"evaluated":[127],"on":[128],"basis":[130],"one-sided":[133],"exact":[134],"binomial":[135],"test":[136],"null":[139,225],"DC":[140,205,229],"rate":[141,230],"15%":[143,228],"versus":[144],"35%":[145],"(power,":[146],"0.84;":[147],"\u03b1,":[148],".10).":[149],"Secondary":[150],"points":[152],"objective":[154],"(OR),":[156],"progression-free":[157],"survival,":[158,160],"overall":[159],"response,":[163],"disease,":[167],"safety.":[169],"RESULTS":[170],"Twenty-eight":[171],"12":[174,213],"tumor":[175],"types":[176],"enrolled":[181],"from":[182],"June":[183,186],"2016":[184],"2021.":[187],"All":[188],"evaluable":[191],"efficacy.":[193],"Two":[194],"PR":[197],"four":[199],"SD16+":[201],"observed":[203],"OR":[207],"rates":[208],"21%":[210],"(90%":[211],"CI,":[212,219],"100)":[215],"7%":[217],"(95%":[218],"1":[220],"24),":[222],"respectively.":[223],"hypothesis":[226],"not":[232,261],"rejected":[233],"(":[234],"P":[235],"=":[236],".24).":[237],"Eight":[238],"one":[243],"grade":[244],"3":[245],"adverse":[246,250],"event":[247,251],"serious":[249],"possibly":[254],"related":[255],"regorafenib.":[257],"CONCLUSION":[258],"Regorafenib":[259],"did":[260],"meet":[262],"prespecified":[263],"criteria":[264],"declare":[266],"signal":[268],"alterations.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-03-07T00:00:00"}